A detailed history of Mai Capital Management transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Mai Capital Management holds 20,000 shares of NWBO stock, worth $5,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$5,400
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$0.66 - $1.15 $13,200 - $23,000
20,000 New
20,000 $15,000

Others Institutions Holding NWBO

About NORTHWEST BIOTHERAPEUTICS INC


  • Ticker NWBO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,037,230,016
  • Market Cap $280M
  • Description
  • Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...
More about NWBO
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.